EP0069399A2
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Pharmaceutical composition containing ubidecarenone containing liposomes
Assignee: Eisai Co Ltd
•
Filing: 1982-07-08
•
Granted: —
•
Expires: 2002-07-08
Abstract
Abstract A ubidecarenone-containing liposome is provided which permits ubidecarenone to be transferred to a target organ at an increased speed. There is also disclosed a pharmaceutical composition containing the ubidecarenone-containing liposome acc. to the invention.
Inventors
- 👤 Masahiro Takada
- 👤 Teruaki Yuzuriha
- 👤 Kouichi Katayama
- 👤 Junzo Sunamoto
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-11-05 09:08
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/10; A61K9/127; A61K9/1277; A61K31/00; A61K31/12; A61K31/122; A61P; A61P9/00
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
3 words
An ubidecarenone-containing liposome
Claim 2
Dependent Claim
3 words
An ubidecarenone-containing liposome
Claim 3
Dependent Claim
15 words
The liposome of claim 1 wherein ubidecarenone is present in the membrane of the liposome.
Claim 4
Dependent Claim
19 words
The liposome of claim 2 wherein the membrane of the liposome is composed of a phospholipid and a sterol.
Claim 5
Dependent Claim
34 words
The liposome of claim 3 wherein the phospholipid is selected from the group consisting of phosphatidyl choline, phosphatidyl ethanolamine, phosphatidyl serine, sphingomyelin, dicetylphosphoric acid, stearylamine, phosphatidyl glycerol, phosphatidic acid, phosphatidyl inositol and mixtures thereof.
Claim 6
Dependent Claim
12 words
The liposome of claim 3 or 4 wherein the sterol is cholesterol.
Claim 7
Dependent Claim
31 words
The liposome of any one of claims 3 to 5 which comprises 1 mole of ubidecarenone, at least 10 moles of the phospholipid, and at least 1 mole of the sterol.
Claim 8
Dependent Claim
26 words
Pharmaceutical composition, characterized in that it contains an ubidecaronone-containing liposome acc. for claims 1 to 6 as active substance besides usual pharmaceutically acceptable carriers and/or diluents.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.